Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm D for Medical and Critical Services Workers

COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3

NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax” or the “Company”), announced that its wholly owned subsidiary Parallax Diagnostics, Inc. has contracted with CURE Pharmaceutical Holding Corp. to distribute CUREfilm D. The supplement that provides a single wrapped CUREfilm that delivers a weekly dose of Vitamin D which has been shown to reduce respiratory infections and boost immune activity is now immediately available for orders at the Company’s website located at www.goodhealthoutcomes.com. 

Support for Vitamin D and infections:

•  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data https://www.bmj.com/content/356/bmj.i6583

•  Former Center for Disease Control, (“CDC”) Chief Dr. Tom Frieden talks: Coronavirus infection risk may be reduced by Vitamin D https://www.foxnews.com/opinion/former-cdc-chief-tom-frieden-coronavir ...

50,000 IU of Vitamin D3 is ideal for:

• • People who have difficulty achieving and maintaining peak vitamin D levels
  • Elderly patients with low vitamin D levels
  • Overweight patients with an elevated body mass index that impairs vitamin D circulation requiring significant repletion doses

Vitamin D3 has been shown to:

• • Prevent respiratory infections
  • Maintain bone and dental health
  • Increase calcium absorption and balance
  • Boost immune activity
  • Support cardiometabolic health, blood sugar balance already within normal levels, and weight loss
  • Help increase musculoskeletal strength and comfort

CUREfilm D offers the following advantages:

• • Uses Cholecalciferol, the ideal form found to maintain active vitamin D levels for an extended period of time
  • High dose of 50,000 IU Vitamin D3 delivered via shelf-stable, individually sealed CUREfilm technology for ease of use and maximum benefit

Robert Davidson Chief Executive Officer of CURE Pharmaceuticals stated, “CURE is committed to social impact in health care.”  Mr. Davidson continued, “We are thankful that Parallax shares the CURE mission to improve lives by redefining how medicines are delivered and experienced. We are honored to supply Vitamin D OTF to the true heroes in this unprecedented time, our front-line health care workers.”